Hypoglycemia

Endocrinology and Metabolism Clinics of North America

Volumn 35, Issue 4, 2006, Pages 753-766

  Guettier, Jean Marc ^a   Gorden, Phillip ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALCOHOL; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C PEPTIDE; CARBOHYDRATE; CHLORPROPAMIDE; DISOPYRAMIDE; GATIFLOXACIN; GLIBENCLAMIDE; GLIPIZIDE; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOCORTICOID; GLUCOSE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR ANTIBODY; LEVOFLOXACIN; PENTAMIDINE; QUINIDINE; QUININE; QUININE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SALICYLIC ACID DERIVATIVE; SOMATOMEDIN B; SOMATOSTATIN; SULFONYLUREA; TOLBUTAMIDE; UNINDEXED DRUG;

ADRENAL CORTEX TUMOR; ADRENERGIC ACTIVITY; AUTOIMMUNE DISEASE; AUTONOMIC NERVOUS SYSTEM; CARCINOID; CENTRAL NERVOUS SYSTEM FUNCTION; CHOLINERGIC ACTIVITY; CORTICOTROPIN DEFICIENCY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG INDUCED DISEASE; DRUG MEGADOSE; DRUG METABOLISM; GENETIC DISORDER; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLYCOGENOLYSIS; GROWTH HORMONE DEFICIENCY; HEMODIALYSIS; HEPATITIS; HUMAN; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN CLEARANCE; INSULIN TREATMENT; INSULINOMA; KIDNEY DISEASE; LEUKEMIA; LIVER CELL CARCINOMA; LIVER DYSFUNCTION; LIVER FAILURE; LYMPHOMA; MEDICAL PRACTICE; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET CELL HYPERPLASIA; PATHOPHYSIOLOGY; PNEUMOCYSTIS PNEUMONIA; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; RISK FACTOR;

BLOOD GLUCOSE; HUMANS; HYPOGLYCEMIA;

EID: 33751230768     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2006.09.005     Document Type: Review

References (100)

1. Merimee T.J., and Tyson J.E. Stabilization of plasma glucose during fasting; normal variations in two separate studies. N Engl J Med 291 24 (1974) 1275-1278
2. Whipple A.O. The surgical therapy of hyperinsulinism. J Int Chir 3 (1938) 237-276
3. Hepburn D.A., Deary I.J., Frier B.M., et al. Symptoms of acute insulin-induced hypoglycemia in humans with and without IDDM. Factor-analysis approach. Diabetes Care 14 11 (1991) 949-957
4. Towler D.A., Havlin C.E., Craft S., et al. Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms. Diabetes 42 12 (1993) 1791-1798
5. Fischer K.F., Lees J.A., and Newman J.H. Hypoglycemia in hospitalized patients. Causes and outcomes. N Engl J Med 315 20 (1986) 1245-1250
6. Holstein A., Plaschke A., and Egberts E.H. Incidence and costs of severe hypoglycemia. Diabetes Care 25 11 (2002) 2109-2110
7. Johnson E.S., Koepsell T.D., Reiber G., et al. Increasing incidence of serious hypoglycemia in insulin users. J Clin Epidemiol 55 3 (2002) 253-259
8. Hart S.P., and Frier B.M. Causes, management and morbidity of acute hypoglycaemia in adults requiring hospital admission. QJM 91 7 (1998) 505-510
9. Vriesendorp T.M., van Santen S., DeVries J.H., et al. Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med 34 1 (2006) 96-101
10. Su C.C. Etiologies of acute hypoglycemia in a Taiwanese hospital emergency department. J Emerg Med 30 3 (2006) 259-261
11. Malouf R., and Brust J.C. Hypoglycemia: causes, neurological manifestations, and outcome. Ann Neurol 17 5 (1985) 421-430
12. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 46 2 (1997) 271-286
13. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 9131 (1998) 837-853
14. Leese G.P., Wang J., Broomhall J., et al. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care 26 4 (2003) 1176-1180
15. Shorr R.I., Ray W.A., Daugherty J.R., et al. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med 157 15 (1997) 1681-1686
16. Service F.J. Hypoglycemic disorders. N Engl J Med 332 17 (1995) 1144-1152
17. Shilo S., Berezovsky S., Friedlander Y., et al. Hypoglycemia in hospitalized nondiabetic older patients. J Am Geriatr Soc 46 8 (1998) 978-982
18. Gerich J., Davis J., Lorenzi M., et al. Hormonal mechanisms of recovery from insulin-induced hypoglycemia in man. Am J Physiol 236 4 (1979) E380-E385
19. Cryer P.E. Glucose counterregulation: prevention and correction of hypoglycemia in humans. Am J Physiol 264 2 Pt 1 (1993) E149-E155
20. Amiel S.A., Sherwin R.S., Simonson D.C., et al. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 37 7 (1988) 901-907
21. Mitrakou A., Fanelli C., Veneman T., et al. Reversibility of unawareness of hypoglycemia in patients with insulinomas. N Engl J Med 329 12 (1993) 834-839
22. Cryer P.E. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 350 22 (2004) 2272-2279
23. Charles M.A., Hofeldt F., Shackelford A., et al. Comparison of oral glucose tolerance tests and mixed meals in patients with apparent idiopathic postabsorptive hypoglycemia: absence of hypoglycemia after meals. Diabetes 30 6 (1981) 465-470
24. Palardy J., Havrankova J., Lepage R., et al. Blood glucose measurements during symptomatic episodes in patients with suspected postprandial hypoglycemia. N Engl J Med 321 21 (1989) 1421-1425
25. Fariss B.L. Prevalence of post-glucose-load glycosuria and hypoglycemia in a group of healthy young men. Diabetes 23 3 (1974) 189-191
26. Hofeldt F.D. Reactive hypoglycemia. Metabolism 24 10 (1975) 1193-1208
27. Lev-Ran A., and Anderson R.W. The diagnosis of postprandial hypoglycemia. Diabetes 30 12 (1981) 996-999
28. Hofeldt F.D. Reactive hypoglycemia. Endocrinol Metab Clin North Am 18 1 (1989) 185-201
29. Service G.J., Thompson G.B., Service F.J., et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 353 3 (2005) 249-254
30. Patti M.E., McMahon G., Mun E.C., et al. Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 48 11 (2005) 2236-2240
31. Meier J.J., Butler A.E., Galasso R., et al. Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased β-cell turnover. Diabetes Care 29 7 (2006) 1554-1559
32. Grunberger G., Weiner J.L., Silverman R., et al. Factitious hypoglycemia due to surreptitious administration of insulin. Diagnosis, treatment, and long-term follow-up. Ann Intern Med 108 2 (1988) 252-257
33. van Staa T., Abenhaim L., and Monette J. Rates of hypoglycemia in users of sulfonylureas. J Clin Epidemiol 50 6 (1997) 735-741
34. Duncan G.G., Jenson W., and Eberly R.J. Factitious hypoglycemia due to chlorpropamide. Report of a case, with clinical similarity to an islet cell tumor of the pancreas. JAMA 175 (1961) 904-906
35. Jordan R.M., Kammer H., and Riddle M.R. Sulfonylurea-induced factitious hypoglycemia. A growing problem. Arch Intern Med 137 3 (1977) 390-393
36. Fernando R. Homicidal poisoning with glibenclamide. Med Sci Law 39 4 (1999) 354-358
37. Manning P.J., Espiner E.A., Yoon K., et al. An unusual cause of hyperinsulinaemic hypoglycaemia syndrome. Diabet Med 20 9 (2003) 772-776
38. Sketris I., Wheeler D., and York S. Hypoglycemic coma induced by inadvertent administration of glyburide. Drug Intell Clin Pharm 18 2 (1984) 142-143
39. Scala-Barnett D.M., and Donoghue E.R. Dispensing error causing fatal chlorpropamide intoxication in a nondiabetic. J Forensic Sci 31 1 (1986) 293-295
40. Field J.B., Williams H.E., and Mortimore G.E. Studies on the mechanism of ethanol-induced hypoglycemia. J Clin Invest 42 (1963) 497-506
41. Lumeng L., and Davis E.J. Mechanism of ethanol suppression of gluconeogenesis. Inhibition of phosphoenolpyruvate synthesis from glutamate and alphaketaglutarate. J Biol Chem 245 12 (1970) 3179-3185
42. Zaleski J., and Bryla J. Ethanol-induced impairment of gluconeogenesis from lactate in rabbit hepatocytes: correlation with an increased reduction of mitochondrial NAD pool. Int J Biochem 11 3-4 (1980) 237-242
43. Madison L.L., Lochner A., and Wulff J. Ethanol-induced hypoglycemia. II. Mechanism of suppression of hepatic gluconeogenesis. Diabetes 16 4 (1967) 252-258
44. Arena F.P., Dugowson C., and Saudek C.D. Salicylate-induced hypoglycemia and ketoacidosis in a nondiabetic adult. Arch Intern Med 138 7 (1978) 1153-1154
45. Raschke R., Arnold-Capell P.A., Richeson R., et al. Refractory hypoglycemia secondary to topical salicylate intoxication. Arch Intern Med 151 3 (1991) 591-593
46. Hirsch I.B., Boyle P.J., Craft S., et al. Higher glycemic thresholds for symptoms during beta-adrenergic blockade in IDDM. Diabetes 40 9 (1991) 1177-1186
47. Poretsky L., and Moses A.C. Hypoglycemia associated with trimethoprim/sulfamethoxazole therapy. Diabetes Care 7 5 (1984) 508-509
48. Waskin H., Stehr-Green J.K., Helmick C.G., et al. Risk factors for hypoglycemia associated with pentamidine therapy for Pneumocystis pneumonia. JAMA 260 3 (1988) 345-347
49. Taylor T.E., Molyneux M.E., Wirima J.J., et al. Blood glucose levels in Malawian children before and during the administration of intravenous quinine for severe falciparum malaria. N Engl J Med 319 16 (1988) 1040-1047
50. Limburg P.J., Katz H., Grant C.S., et al. Quinine-induced hypoglycemia. Ann Intern Med 119 3 (1993) 218-219
51. Barbato M. Another problem with Kinidin. Med J Aust 141 10 (1984) 685
52. Goldberg I.J., Brown L.K., and Rayfield E.J. Disopyramide (Norpace)-induced hypoglycemia. Am J Med 69 3 (1980) 463-466
53. Graumlich J.F., Habis S., Avelino R.R., et al. Hypoglycemia in inpatients after gatifloxacin or levofloxacin therapy: nested case-control study. Pharmacotherapy 25 10 (2005) 1296-1302
54. Park-Wyllie L.Y., Juurlink D.N., Kopp A., et al. Outpatient gatifloxacin therapy and dysglycemia in older adults. N Engl J Med 354 13 (2006) 1352-1361
55. Chiolero R., Tappy L., Gillet M., et al. Effect of major hepatectomy on glucose and lactate metabolism. Ann Surg 229 4 (1999) 505-513
56. Luo J.C., Hwang S.J., Wu J.C., et al. Paraneoplastic syndromes in patients with hepatocellular carcinoma in Taiwan. Cancer 86 5 (1999) 799-804
57. Felig P., Brown W.V., Levine R.A., et al. Glucose homeostasis in viral hepatitis. N Engl J Med 283 26 (1970) 1436-1440
58. Gerich J.E., Meyer C., Woerle H.J., et al. Renal gluconeogenesis: its importance in human glucose homeostasis. Diabetes Care 24 2 (2001) 382-391
59. Sovik O., Oseid S., and Vidnes J. Ketotic hypoglycemia in a four-year-old boy with adrenal cortical insufficiency. Acta Paediatr Scand 61 4 (1972) 465-469
60. Artavia-Loria E., Chaussain J.L., Bougneres P.F., et al. Frequency of hypoglycemia in children with adrenal insufficiency. Acta Endocrinol Suppl (Copenh) 279 (1986) 275-278
61. Pia A., Piovesan A., Tassone F., et al. A rare case of adulthood-onset growth hormone deficiency presenting as sporadic, symptomatic hypoglycemia. J Endocrinol Invest 27 11 (2004) 1060-1064
62. Nadler H.L., Neumann L.L., and Gershberg H. Hypoglycemia, growth retardation, and probable isolated growth hormone deficiency in a 1-year-old child. J Pediatr 63 (1963) 977-983
63. LaFranchi S., Buist N.R., Jhaveri B., et al. Amino acids as substrates in children with growth hormone deficiency and hypoglycemia. Pediatrics 68 2 (1981) 260-264
64. Wolfsdorf J.I., Sadeghi-Nejad A., and Senior B. Hypoketonemia and age-related fasting hypoglycemia in growth hormone deficiency. Metabolism 32 5 (1983) 457-462
65. De Feo P., Perriello G., Torlone E., et al. Demonstration of a role for growth hormone in glucose counterregulation. Am J Physiol 256 6 Pt 1 (1989) E835-E843
66. De Feo P., Perriello G., Torlone E., et al. Contribution of cortisol to glucose counterregulation in humans. Am J Physiol 257 1 Pt 1 (1989) E35-E42
67. Khani S., and Tayek J.A. Cortisol increases gluconeogenesis in humans: its role in the metabolic syndrome. Clin Sci (Lond) 101 6 (2001) 739-747
68. Boyle P.J., and Cryer P.E. Growth hormone, cortisol, or both are involved in defense against, but are not critical to recovery from, hypoglycemia. Am J Physiol 260 3 Pt 1 (1991) E395-E402
69. Megyesi K., Kahn C.R., Roth J., et al. Hypoglycemia in association with extrapancreatic tumors: demonstration of elevated plasma NSILA-s by a new radioreceptor assay. J Clin Endocrinol Metab 38 5 (1974) 931-934
70. Gorden P., Hendricks C.M., Kahn C.R., et al. Hypoglycemia associated with non-islet-cell tumor and insulin-like growth factors. N Engl J Med 305 24 (1981) 1452-1455
71. Daughaday W.H., Emanuele M.A., Brooks M.H., et al. Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia. N Engl J Med 319 22 (1988) 1434-1440
72. Daughaday W.H., and Kapadia M. Significance of abnormal serum binding of insulinlike growth factor II in the development of hypoglycemia in patients with nonislet- cell tumors. Proc Natl Acad Sci USA 86 17 (1989) 6778-6782
73. Daughaday W.H., and Trivedi B. Measurement of derivatives of proinsulin-like growth factor-II in serum by a radioimmunoassay directed against the E-domain in normal subjects and patients with nonislet cell tumor hypoglycemia. J Clin Endocrinol Metab 75 1 (1992) 110-115
74. Wu J.C., Daughaday W.H., Lee S.D., et al. Radioimmunoassay of serum IGF-I and IGF-II in patients with chronic liver diseases and hepatocellular carcinoma with or without hypoglycemia. J Lab Clin Med 112 5 (1988) 589-594
75. Ishida S., Noda M., Kuzuya N., et al. Big insulin-like growth factor II-producing hepatocellular carcinoma associated with hypoglycemia. Intern Med 34 12 (1995) 1201-1206
76. Todd J.F., Stanley S.A., Roufosse C.A., et al. A tumour that secretes glucagon-like peptide-1 and somatostatin in a patient with reactive hypoglycaemia and diabetes. Lancet 361 9353 (2003) 228-230
77. Shetty M.R., Boghossian H.M., Duffell D., et al. Tumor-induced hypoglycemia: a result of ectopic insulin production. Cancer 49 9 (1982) 1920-1923
78. Morgello S., Schwartz E., Horwith M., et al. Ectopic insulin production by a primary ovarian carcinoid. Cancer 61 4 (1988) 800-805
79. Seckl M.J., Mulholland P.J., Bishop A.E., et al. Hypoglycemia due to an insulin-secreting small-cell carcinoma of the cervix. N Engl J Med 341 10 (1999) 733-736
80. Service F.J., Dale A.J., Elveback L.R., et al. Insulinoma: clinical and diagnostic features of 60 consecutive cases. Mayo Clin Proc 51 7 (1976) 417-429
81. Service F.J., McMahon M.M., O'Brien P.C., et al. Functioning insulinoma-incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 66 7 (1991) 711-719
82. Hirshberg B., Livi A., Bartlett D.L., et al. Forty-eight-hour fast: the diagnostic test for insulinoma. J Clin Endocrinol Metab 85 9 (2000) 3222-3226
83. Service F.J., Natt N., Thompson G.B., et al. Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes. J Clin Endocrinol Metab 84 5 (1999) 1582-1589
84. Thompson G.B., Service F.J., Andrews J.C., et al. Noninsulinoma pancreatogenous hypoglycemia syndrome: an update in 10 surgically treated patients. Surgery 128 6 (2000) 937-944 [discussion: 944-5]
85. Kane C., Shepherd R.M., Squires P.E., et al. Loss of functional KATP channels in pancreatic beta-cells causes persistent hyperinsulinemic hypoglycemia of infancy. Nat Med 2 12 (1996) 1344-1347
86. Nestorowicz A., Wilson B.A., Schoor K.P., et al. Mutations in the sulonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews. Hum Mol Genet 5 11 (1996) 1813-1822
87. Thomas P., Ye Y., and Lightner E. Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy. Hum Mol Genet 5 11 (1996) 1809-1812
88. Nestorowicz A., Inagaki N., Gonoi T., et al. A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism. Diabetes 46 11 (1997) 1743-1748
89. Glaser B., Kesavan P., Heyman M., et al. Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med 338 4 (1998) 226-230
90. Stanley C.A., Lieu Y.K., Hsu B.Y., et al. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med 338 19 (1998) 1352-1357
91. Khokher M.A., Avasthy N., Taylor A.M., et al. Insulin-receptor antibody and hypoglycaemia associated with Hodgkin's disease. Lancet 1 8534 (1987) 693-694
92. Moller D.E., Ratner R.E., Borenstein D.G., et al. Autoantibodies to the insulin receptor as a cause of autoimmune hypoglycemia in systemic lupus erythematosus. Am J Med 84 2 (1988) 334-338
93. Arioglu E., Andewelt A., Diabo C., et al. Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective. Medicine (Baltimore) 81 2 (2002) 87-100
94. Taylor S.I., Barbetti F., Accili D., et al. Syndromes of autoimmunity and hypoglycemia. Autoantibodies directed against insulin and its receptor. Endocrinol Metab Clin North Am 18 1 (1989) 123-143
95. Hirata Y., Tominaga M., Ito J.I., et al. Spontaneous hypoglycemia with insulin autoimmunity in Graves' disease. Ann Intern Med 81 2 (1974) 214-218
96. Redmon B., Pyzdrowski K.L., Elson M.K., et al. Hypoglycemia due to an insulin-binding monoclonal antibody in multiple myeloma. N Engl J Med 326 15 (1992) 994-998
97. Blackshear P.J., Rotner H.E., Kriauciunas K.A., et al. Reactive hypoglycemia and insulin autoantibodies in drug-induced lupus erythematosus. Ann Intern Med 99 2 (1983) 182-184
98. Gorden P., Skarulis M.C., Roach P., et al. Plasma proinsulin-like component in insulinoma: a 25-year experience. J Clin Endocrinol Metab 80 10 (1995) 2884-2887
99. Gruppuso P.A., Gorden P., Kahn C.R., et al. Familial hyperproinsulinemia due to a proposed defect in conversion of proinsulin to insulin. N Engl J Med 311 10 (1984) 629-634
100. Hirshberg B., Cochran C., Skarulis M.C., et al. Malignant insulinoma: spectrum of unusual clinical features. Cancer 104 2 (2005) 264-272